Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 373 - BOARD OF LICENSURE IN MEDICINE › Chapter 12 - JOINT RULE REGARDING OFFICE BASED TREATMENT OF OPIOID USE DISORDER › Section 373-12-1 - DEFINITIONS

Current through 2024-29, July 17, 2024
1.
Administrative Discharge
means the involuntary process of medically supervised withdrawal from
				medications for Opioid Use Disorder.
2.
Approved Medications
means
				medications that are FDA approved for the treatment of Opioid Use Disorder
				(OUD) in an office based setting that is not a certified Opioid Treatment
				Program (OTP).
3.
ASAM
means the American Society of Addiction Medicine.
4.
Board
means the Board of
				Licensure in Medicine, the State Board of Nursing, and the Board of Osteopathic
				Licensure.
5.
Clinical
				Discharge
means the voluntary process, agreed upon by both the patient
				and provider, of medically-supervised withdrawal by gradually tapering
				medication for ultimate cessation of therapy.
6.
Clinician
means a
				Maine-licensed physician, physician assistant, or advanced practice registered
				nurse.
7.
Co-occurring
				Disorder
means an individual who has a co-existing mental illness and a
				substance use disorder.
8.
DATA 2000
means the federal Drug Addiction Treatment Act of 2000,
				which permits clinicians who meet certain qualifications to treat individuals
				with OUD by prescribing FDA Approved Medications such as
				buprenorphine.
9.
DATA 2000
				Waiver
means a DEA authorization for a licensed clinician who has met
				the training and credentialing registration requirements of DATA 2000 to
				prescribe Approved Medications to patients in settings other than
				OTPs.
10.
DEA
means
				the Drug Enforcement Administration in the U.S. Department of
				Justice.
11.
Drug
				Diversion
means the transfer of a controlled substance from authorized
				legal and medically necessary use or possession to illegal and unauthorized use
				or possession.
12.
FDA
means the U.S. Food and Drug Administration.
13.
Informed Consent
means
				written agreement by a patient to a medical procedure, or for participation in
				OBOT, after achieving an understanding of the relevant medical facts, risks and
				benefits, and alternative treatments.
14.
Medical Emergency
means an
				acute injury or illness that poses an immediate risk to a person's life or
				long-term health.
15.
Misuse
means all uses of a prescription medication other than
				those that are directed by a clinician in accordance with the plan of
				treatment.
16.
Office Based
				Opioid Treatment (OBOT)
means providing medication and other
				non-pharmacologic modalities to treat OUD in outpatient medical settings other
				than certified OTPs. OBOT does not include the administration of buprenorphine
				in any setting that allows a clinician who is not certified as a waivered DATA
				2000 clinician to administer (but not prescribe) buprenorphine to a patient for
				the purpose of relieving acute withdrawal symptoms while arranging for a
				patient's referral for treatment and provided that in accordance with Title 21,
				Code of Federal Regulations, Part 1306.07(b):
(1) not more than one day's medication may be
				administered to a patient at one time;
(2) the treatment may not be carried out for
				more than 72 hours; and
(3) the 72
				hour period cannot be renewed or extended.